Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats

International Journal of Neuropsychopharmacology

Volumn 2, Issue 1, 1999, Pages 17-23

  DeVane, C Lindsay ^a   Boulton, David W ^b   Miller, Lisa F ^b   Miller, Ronald L ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

m chlorophenylpiperazine (m CPP); Mini osmotic pumps; Pharmacokinetics; Placental transfer; Pregnancy; Serotonin; Trazodone

Indexed keywords

EID: 0346608483     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145799001303     Document Type: Article

References (30)

1. Abernethy DR, Greenblatt DJ, Shader RI (1984). Plasma levels of trazodone: Methodology and applications. Pharmacology 28, 42-46.
2. Allroy L, Catanese B, Cioli C, Interdonato N (1978). A study of serum levels of trazodone produced in man following single or repeated oral administrations. Bolettino Chimico Farmaceutico 11, 530-533.
3. Ankier SI, Martin BK, Rogers MS, Carpenter PK, Graham C (1981). Trazodone - a new assay procedure and some pharmacokinetic parameters. British Journal of Clinical Pharmacology 11, 505-509.
4. Aulakh CS, Wozniak KM, Hill JL, DeVane CL, Tolliver TJ, Murphy DL (1988). Differential neuroendocrine responses to the 5 HT agonist m-chlorophenylpiperazine in Fawn Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 48, 401-406.
5. Barbhaiya RH, Buch AB, Greene DS (1996). Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan. British Journal of Clinical Pharmacology 42, 573-581.
6. Bayer AJ, Pathy MSJ, Ankier SI (1983). Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. British Journal of Clinical Pharmacology 16, 371-376.
7. Brogden RN, Heel RC, Speight TM, Avery GS (1981). Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21, 401-419.
8. Caccia S, Ballabio M, Fanelli R (1981b). Determination of plasma and brain concentrations of trazodone and its metabolite 1-m-chlorophenylpiperazine by gas liquid chromatography. Journal of Chromatography 210, 311-318.
9. Caccia S, Ballabio M, Samanin R (1981a). m-Chlorophenylpiperazine, a 5-hydroxytryptamine agonist, is a metabolite of trazodone. Journal of Pharmacy and Pharmacology 33, 477-479.
10. Caccia S, Fong MH, Garattini S, Zanini MG (1982). Plasma concentrations of trazodone and 1-(3)-chlorophenylpiperazine in man after a single oral dose of trazodone. Journal of Pharmacy and Pharmacology 34, 605-606.
11. Calabrese JR, Gulledge AD (1985). Psychotropics during pregnancy and lactation: A review. Psychosomatics 26, 413-426.
12. Cervo L, Ballabio M, Caccia S, Samanin R (1981). Blockade by trazodone of naloxone precipitated jumping in morphine dependent rats; correlation with brain levels of m-chlorophenylpiperazine. Journal of Pharmacy and Pharmacology 33, 813-814.
13. DeVane CL, Laizure SC (1986). The effect of experimentally induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs. Psychopharmacology 89, 404-408.
14. DeVane CL, Simpkins JW (1985). Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose. Drug Metabolism and Disposition 13, 438-442.
15. Fong MH, Garattini S, Caccia S (1982a). 1-m-chlorophenyl-piperazine is an active metabolite common to the psychotropic drug trazodone, etoperidone, and mepiprazole. Journal of Pharmacy and Pharmacology 34, 674-675.
16. Fong MH, Garattini S, Zanini MG (1982b). Plasma concentrations of trazodone and 1-(2-chlorophenyl)-piperazine in man after a single oral dose of trazodone. Journal of Pharmacy and Pharmacology 34, 605-606.
17. Friedman E, Cooper TB (1983). Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. Journal of Pharmacology and Experimental Therapeutics 225, 387-390.
18. Greenblatt DJ, Friedman H, Burstein ES, Scavone JM, Blyden GT, Ochs HR, Miller LG, Harmatz JS, Shader RT (1987). Trazodone kinetics: effect of age, gender and obesity. Clinical Pharmacology and Therapeutics 42, 193-200.
19. Ishida M, Otani K, Kaneko S, Ohkubo T, Osanai T, Yasui N, Mihara K, Higuchi H, Sugawara K (1995). Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. International Clinical Psychopharmacology 10, 143-146.
20. Lawlor BA, Radcliffe J, Martinez R, Sunderland T, Murphy DL (1997). Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers. Biological Psychiatry 41, 756-757.
21. Maj J, Palider W, Rawlow A (1979). Trazodone, a central serotonin antagonist and agonist. Journal of Neural Transmission 44, 237-247.
22. Martin A, Pounder DJ (1992). Post-mortem toxico-kinetics of trazodone. Forensic Science International 56, 201-207.
23. Melzacka M, Baska J, Maj J (1979). 1-m-chlorophenyl-piperazine: a metabolite of trazodone isolated from rat urine. Journal of Pharmacy and Pharmacology 31, 855-856.
24. Miller RL, DeVane CL (1986). Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high performance liquid chromatography. Journal of Chromatography 374, 388-393.
25. Nilsen OG, Dale O, Husebo B (1993). Pharmacokinetics of trazodone during multiple doing to psychiatric patients. Pharmacology and Toxicology 72, 286-289.
26. Rotzinger S, Fang J, Baker GB (1998). Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metabolism and Disposition 26, 572-575.
27. Rurak A, Melzacka M (1983). Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats. Polish Journal of Pharmacology and Pharmacy 35, 241-247.
28. Smith TM, Suckow RF (1985). Trazodone and m-chlorophenylpiperazine: concentration in brain and receptor activity in regions in the brain associated with anxiety. Neuropharmacology 25, 1-5.
29. Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1989a). Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology 97, 269-274.
30. Wozniak KM, Aulakh CS, Hill JL and Murphy DL (1989b). Differential effect of clomipramine treatment on m-chlorophenylpiperazine induced increases in plasma prolactin and corticosterone in rats. Pharmacology, Biochemistry and Behavior 33, 265-267.